Evoke Pharma EVOK Stock
0.51 USD
{{ price }}
-5.555561%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
4.32M USD
LOW - HIGH [24H]
0.5
-
0.54 USD
VOLUME [24H]
32.58K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.33 USD
Evoke Pharma Price Chart
Evoke Pharma EVOK Financial and Trading Overview
| Evoke Pharma stock price | 0.51 USD |
| Previous Close | 1.17 USD |
| Open | 1.11 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 1300 |
| Day's Range | 1.11 - 1.22 USD |
| 52 Week Range | 1.11 - 5.96 USD |
| Volume | 3.83K USD |
| Avg. Volume | 27.13K USD |
| Market Cap | 3.88M USD |
| Beta (5Y Monthly) | 0.332178 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
EVOK Valuation Measures
| Enterprise Value | 2.12M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.611111 |
| PEG Ratio (5 yr expected) | -0.01 |
| Price/Sales (ttm) | 1.0861884 |
| Price/Book (mrq) | 7.204969 |
| Enterprise Value/Revenue | 0.595 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Evoke Pharma Stock Price History
| Beta (5Y Monthly) | 0.332178 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 5.96 USD |
| 52 Week Low | 1.11 USD |
| 50-Day Moving Average | 1.56 USD |
| 200-Day Moving Average | 2.22 USD |
EVOK Share Statistics
| Avg. Volume (3 month) | 27.13K USD |
| Avg. Daily Volume (10-Days) | 17.24K USD |
| Shares Outstanding | 3.34M |
| Float | 3.26M |
| Short Ratio | 1.08 |
| % Held by Insiders | 2.46% |
| % Held by Institutions | 2.07% |
| Shares Short | 6.61K |
| Short % of Float | 0.20% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -222.058% |
| Operating Margin (ttm) | -211.80% |
| Gross Margin | 89.13% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.42% |
| Return on Equity (ttm) | -205.14% |
Income Statement
| Revenue (ttm) | 3.57M USD |
| Revenue Per Share (ttm) | 1.07 USD |
| Quarterly Revenue Growth (yoy) | 145.00% |
| Gross Profit (ttm) | 2.14M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -7928072 USD |
| Diluted EPS (ttm) | -2.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.01M USD |
| Total Cash Per Share (mrq) | 2.1 USD |
| Total Debt (mrq) | 5.05M USD |
| Total Debt/Equity (mrq) | 938.54 USD |
| Current Ratio (mrq) | 4.29 |
| Book Value Per Share (mrq) | 0.161 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6444518 USD |
| Levered Free Cash Flow (ttm) | -4055114 USD |
Profile of Evoke Pharma
| Country | United States |
| State | CA |
| City | Solana Beach |
| Address | 420 Stevens Avenue |
| ZIP | 92075 |
| Phone | 858 345 1494 |
| Website | https://evokepharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Q&A For Evoke Pharma Stock
What is a current EVOK stock price?
Evoke Pharma EVOK stock price today per share is 0.51 USD.
How to purchase Evoke Pharma stock?
You can buy EVOK shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evoke Pharma?
The stock symbol or ticker of Evoke Pharma is EVOK.
Which industry does the Evoke Pharma company belong to?
The Evoke Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Evoke Pharma have in circulation?
The max supply of Evoke Pharma shares is 8.48M.
What is Evoke Pharma Price to Earnings Ratio (PE Ratio)?
Evoke Pharma PE Ratio is now.
What was Evoke Pharma earnings per share over the trailing 12 months (TTM)?
Evoke Pharma EPS is -2.33 USD over the trailing 12 months.
Which sector does the Evoke Pharma company belong to?
The Evoke Pharma sector is Healthcare.
Evoke Pharma EVOK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}